Mesa Laboratories Inc
NASDAQ:MLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
US |
|
S
|
Sanford Ltd
OTC:SARDY
|
NZ |
|
AMP Ltd
ASX:AMP
|
AU |
|
Yourgene Health PLC
LSE:YGEN
|
UK |
|
CVC Ltd
ASX:CVC
|
AU |
|
Lagardere SA
PAR:MMB
|
FR |
|
Nestle SA
F:NESR
|
CH |
|
Geo Energy Resources Ltd
SGX:RE4
|
SG |
|
P
|
Power Line Engineering PCL
SET:PLE
|
TH |
|
First Capital Inc
NASDAQ:FCAP
|
US |
|
R
|
RXO Inc
NYSE:RXO
|
US |
Wall Street
Price Targets
MLAB Price Targets Summary
Mesa Laboratories Inc
According to Wall Street analysts, the average 1-year price target for
MLAB
is 106.59 USD
with a low forecast of 94.94 USD and a high forecast of 120.75 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MLAB's stock price target?
Price Target
106.59
USD
According to Wall Street analysts, the average 1-year price target for
MLAB
is 106.59 USD
with a low forecast of 94.94 USD and a high forecast of 120.75 USD.
What is Mesa Laboratories Inc's Revenue forecast?
Projected CAGR
5%
For the last 13 years the
compound annual growth rate for
Mesa Laboratories Inc's revenue is
15%.
The projected
CAGR
for the next 3 years is
5%.
What is Mesa Laboratories Inc's Operating Income forecast?
Projected CAGR
17%
For the last 13 years the
compound annual growth rate for
Mesa Laboratories Inc's operating income is
2%.
The projected
CAGR
for the next 3 years is
17%.
